ISPOR - PMS14 Cost of Etanercept, Adalimumab, and Infliximab Per Treated Patient Across Adult Indications Using Real-World Data

Full Text

PMS14 Cost of Etanercept, Adalimumab, and Infliximab Per Treated Patient Across Adult Indications Using Real-World Data

Abstract

Authors

M. Bonafede S.R. Gandra C. Watson N. Princic K.M. Fox

Back to Volume 14, Issue 7

Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now